Source: International Congress 2016 – Clinical and molecular studies in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ioana Agache (Brasov, Romania), Ioana Agache, Daniel S. Strassser, Axel Klenk, Costel Agache, Hervé Farine, Cristina Ciobanu, Peter M.A. Groenen, Cezmi A. Akdis. Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics. Eur Respir J 2016; 48: Suppl. 60, 1984

Member's Comments

No comment yet.

Related content which might interest you: Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Peripheral blood Th9 cells and IL-9 level in asthma patients with early and dual asthmatic response Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma Year: 2015 The prognostic value of IFN-gamma and IL-4 cytokines ratio and CD25+ lymphocytes blood content for asthma exacerbation Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Relation between concentration of TNF-apha, IL-6, CRP and airway hyperresponsiveness in elderly asthmatics Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Blood eosinophils relate more closely to reduced lung function than serum ECP or plasma EDN in young asthmatics Source: International Congress 2016 – Systemic biomarkers Year: 2016 Systemic cytokine signaling via IL-17 and its relation to clinical characteristics in children with asthma Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers Year: 2015 TH2 specific biomarker profile determines steroid responsiveness in severe asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Proinflammatory cytokines and IP-10 differentiate neutrophilic and eosinophilic asthma subgroups Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Correlation between asthma control and serum levels of IL-33 in atopic asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Evaluation of inflammatory markers IL-6 and MMP-9 in asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 The combination of elevated FeNO and blood eosinophils relate to reduced lung function and increased bronchial responsiveness in young asthmatics Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Higher burden of asthma symptoms and increased blood eosinophils in ACOS Source: International Congress 2016 – Systemic biomarkers Year: 2016 Peripheral blood eosinophilia predicts lower airway eosinophilia in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 The role of IL-13, IL-4Rα cytokine gene variants in atopic and non-atopic asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015 LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma Source: Annual Congress 2013 –Asthma Year: 2013 Interleukin-33 and Th2 cytokines correlate in acute asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Serum levels of IL-10, IL-17F, and IL-33 in asthmatic patients of south India Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 TNFAIP3 (A20) expression is elevated in the sputum of severe asthmatics Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016